- Home
- ITCI vs TX Comparison
ITCI vs TX Comparison
Compare ITCI & TX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITCI
- TX
- Stock Information
- Founded
- ITCI 2002
- TX 1961
- Country
- ITCI United States
- TX Luxembourg
- Employees
- ITCI N/A
- TX N/A
- Industry
- ITCI Biotechnology: Pharmaceutical Preparations
- TX Steel/Iron Ore
- Sector
- ITCI Health Care
- TX Industrials
- Exchange
- ITCI Nasdaq
- TX Nasdaq
- Market Cap
- ITCI 8.0B
- TX 6.7B
- IPO Year
- ITCI N/A
- TX 2006
- Fundamental
- Price
- ITCI $86.00
- TX $29.01
- Analyst Decision
- ITCI Strong Buy
- TX Strong Buy
- Analyst Count
- ITCI 12
- TX 2
- Target Price
- ITCI $97.67
- TX $55.00
- AVG Volume (30 Days)
- ITCI 455.4K
- TX 196.6K
- Earning Date
- ITCI 02-20-2025
- TX 02-18-2025
- Dividend Yield
- ITCI N/A
- TX 10.68%
- EPS Growth
- ITCI N/A
- TX N/A
- EPS
- ITCI N/A
- TX 0.40
- Revenue
- ITCI $613,728,000.00
- TX $18,703,544,000.00
- Revenue This Year
- ITCI $48.41
- TX $6.38
- Revenue Next Year
- ITCI $38.26
- TX $2.14
- P/E Ratio
- ITCI N/A
- TX $71.45
- Revenue Growth
- ITCI 46.08
- TX 15.27
- 52 Week Low
- ITCI $62.78
- TX $28.58
- 52 Week High
- ITCI $93.45
- TX $44.44
- Technical
- Relative Strength Index (RSI)
- ITCI 54.91
- TX 29.16
- Support Level
- ITCI $82.76
- TX $28.58
- Resistance Level
- ITCI $89.12
- TX $29.32
- Average True Range (ATR)
- ITCI 2.48
- TX 0.80
- MACD
- ITCI -0.04
- TX -0.17
- Stochastic Oscillator
- ITCI 59.75
- TX 9.84
About ITCI Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.
About TX Ternium S.A. Ternium S.A. (each representing ten shares USD1.00 par value)
Ternium SA is a flat steel producer operating in Mexico, Brazil, Argentina, Colombia, the southern United States, and Central America. It produces finished and semi-finished steel products and iron ore, which are sold either directly to steel manufacturers and steel processors or end-users. The company operates in two segments: Steel, Usiminas and Mining. In its steel segment, the company produces slabs, billets & round bars, hot-rolled coils & sheets, bars & stirrups, wire rods, steel pipes, and other products. The Mining segment sells iron ore as concentrates (fines) and pellets. The Usiminas segment include iron ore extraction, steel transformation, production of capital goods and logistics. The vast majority of its revenue comes from the steel segment and geographically from Mexico.